Business description: ThermoGenesis Holdings, Inc.

ThermoGenesis Holdings, Inc. develops and commercializes a range of automated technologies for cell-banking, cell-processing, and cell-based therapeutics. The Company provides the AutoXpress and BioArchive platforms for automated clinical bio-banking, the PXP platform for point-of-care cell-based therapies and X-Series products for cell processing services. Its product lines include Clinical Bio-Banking Applications, Point-of-Care Applications and Cell Processing. Its Clinical Bio-Banking Applications include AXP II Automated Cell Separation System and BioArchive Automated Cryopreservation System. Its Point-of-Care Applications include PXP Point-of-Care System, and PXP-1000 System. Its Cell Processing includes X-Series Products for general laboratory use: X-Lab for cell isolation, X-Wash System for cell washing and reformulation, and X-Mini for high efficiency small scale cell purification. The Company markets and sells its medical device products through independent distributors.

Number of employees: 25

Sales by Activity: ThermoGenesis Holdings, Inc.

Fiscal Period: December20192020202120222023

Device

12.96M 9.74M - 10.48M 9.44M

Clinical Development

90K - - - -
See all business segments

Geographical breakdown of sales: ThermoGenesis Holdings, Inc.

Fiscal Period: December20192020202120222023

United States

6.79M - - 6.64M 6.03M

Other

573K - - 798K 2.52M

United Arab Emirates

- - - - 570K

Vietnam

- - - 515K 225K

China

2.35M - - 1.98M 98K

South Korea

- - - 536K -

Thailand

- - - 9K -

Asia - Other

2.11M - - - -

Europe

1.23M - - - -
See all geographic segments

Executive Committee: ThermoGenesis Holdings, Inc.

Manager TitleAgeSince
Chief Executive Officer 54 2016-11-02
Investor Relations Contact - -
See THERMOGENESIS HOLDINGS, INC. governance

Composition of the Board of Directors: ThermoGenesis Holdings, Inc.

Director TitleAgeSince
Chairman 54 2016-11-02
Director/Board Member - 2023-07-13
Composition of the Board of Directors

Shareholders: ThermoGenesis Holdings, Inc.

NameEquities%Valuation
77.84 %
12,335,016 77.84 % 8 635 $
0.000126 %
20 0.000126 % 0 $
0 %
0 0 % - $
0 %
0 0 % - $
Boyalife Group Co. Ltd.
0 %
0 0 % - $
List of THERMOGENESIS HOLDINGS, INC. shareholders

Company details: ThermoGenesis Holdings, Inc.

ThermoGenesis Holdings, Inc.

2890 Kilgore Road

95670, Rancho Cordova

+916 858 5100

http://www.thermogenesis.com
address ThermoGenesis Holdings, Inc.(THMO)

Scientific & Precision Equipment

Change 5d. change 1-year change 3-years change Capi.($)
-99.00%-.--% - - 15
-2.12%-3.15%-13.98%+0.83% 24.81B
-0.71%-3.22%-20.96%-25.33% 6.69B
+0.31%-.--%-.--%+68.37% 3.25B
-0.74%-0.62%-50.28%-50.89% 2.58B
+0.31%+3.20%+211.31% - 2.04B
+1.20%+4.10%+51.30%+89.68% 1.62B
-0.49%+3.24%+70.80%+228.99% 1.53B
-0.66%-0.46%-38.43%-20.06% 1.51B
+0.34%+5.40%+42.58%-17.92% 1.37B
Average -10.17%+1.37%+28.04%+34.21% 4.54B
Weighted average by Cap. -1.26%+0.69%+0.15%+8.85%
See all sector performances
  1. Stock Market
  2. Equities
  3. THMO Stock
  4. Company ThermoGenesis Holdings, Inc.